Estrogen inhibits interleukin-6 production and gene expression in a human osteoblastic cell line with high levels of estrogen receptors - PubMed (original) (raw)
Estrogen inhibits interleukin-6 production and gene expression in a human osteoblastic cell line with high levels of estrogen receptors
M Kassem et al. J Bone Miner Res. 1996 Feb.
Abstract
Some studies suggest that estrogen acts on bone by decreasing the production of interleukin-6 (IL-6), a cytokine that increases bone resorption, by osteoblasts or bone marrow cells. However, other studies have not confirmed this, possibly because of a low and variable number of estrogen receptors (ER) in the model systems used. Thus, we employed a recently developed human fetal osteoblast cell line with high levels of ER. Treatment (n = 4 experiments) with 0.01 to 10 nM of 17 beta-estradiol had no effect on the constitutive production of IL-6. However, stimulated production, induced by treatment with IL-1 beta plus tumor necrosis factor-alpha (TNF-alpha), was reduced in a dose-dependent manner to 74 +/- 3% (mean +/- SEM) of control (p < 0.01). This response was blocked by cotreatment with the type II antiestrogen ICI 182,780. Treatment with hydrocortisone (1 microM), a known inhibitor of IL-6 production in many cell types, reduced IL-6 production to 17 +/- 1% of control (p < 0.001). As assessed by Northern analysis, treatment (n = 3 experiments) with 0.01-10 nM of 17 beta-estradiol decreased steady-state levels of IL-6 mRNA in a dose-dependent manner. These data support the hypothesis that at least part of the antiresorptive action of estrogen in humans is mediated by decreased production of IL-6 by osteoblastic cells.
Similar articles
- The anti-androgen hydroxyflutamide and androgens inhibit interleukin-6 production by an androgen-responsive human osteoblastic cell line.
Hofbauer LC, Ten RM, Khosla S. Hofbauer LC, et al. J Bone Miner Res. 1999 Aug;14(8):1330-7. doi: 10.1359/jbmr.1999.14.8.1330. J Bone Miner Res. 1999. PMID: 10457265 - Phytoestrogen genistein acts as an estrogen agonist on human osteoblastic cells through estrogen receptors alpha and beta.
Rickard DJ, Monroe DG, Ruesink TJ, Khosla S, Riggs BL, Spelsberg TC. Rickard DJ, et al. J Cell Biochem. 2003 Jun 1;89(3):633-46. doi: 10.1002/jcb.10539. J Cell Biochem. 2003. PMID: 12761896 - Cellular and molecular effects of growth hormone and estrogen on human bone cells.
Kassem M. Kassem M. APMIS Suppl. 1997;71:1-30. APMIS Suppl. 1997. PMID: 9357492 Review. - Potential mechanism of estrogen-mediated decrease in bone formation: estrogen increases production of inhibitory insulin-like growth factor-binding protein-4.
Kassem M, Okazaki R, De León D, Harris SA, Robinson JA, Spelsberg TC, Conover CA, Riggs BL. Kassem M, et al. Proc Assoc Am Physicians. 1996 Mar;108(2):155-64. Proc Assoc Am Physicians. 1996. PMID: 8705735
Cited by
- Effects of 17beta-estradiol on the expression of IL-6, IL-11 and NF-kappaB in human MG-63 osteoblast-like cell line.
Wang Y, Liao E, Xiang G, Dai R, Xiao X, Luo X. Wang Y, et al. J Huazhong Univ Sci Technolog Med Sci. 2006;26(1):53-8. doi: 10.1007/BF02828038. J Huazhong Univ Sci Technolog Med Sci. 2006. PMID: 16711008 - Hormone replacement therapy in rheumatoid arthritis is associated with lower serum levels of soluble IL-6 receptor and higher insulin-like growth factor 1.
D'Elia HF, Mattsson LA, Ohlsson C, Nordborg E, Carlsten H. D'Elia HF, et al. Arthritis Res Ther. 2003;5(4):R202-9. doi: 10.1186/ar761. Epub 2003 May 1. Arthritis Res Ther. 2003. PMID: 12823855 Free PMC article. Clinical Trial. - Cross-sectional study investigating the association between inflammatory biomarkers and neuropathy in adolescents with type 1 diabetes.
Rasmussen VF, Hirschberg Jensen V, Thrysøe M, Vestergaard ET, Størling J, Kristensen K. Rasmussen VF, et al. BMJ Open. 2023 Oct 6;13(10):e074992. doi: 10.1136/bmjopen-2023-074992. BMJ Open. 2023. PMID: 37802616 Free PMC article. - DHEA and the skeleton (through the ages).
Gordon CM, Glowacki J, LeBoff MS. Gordon CM, et al. Endocrine. 1999 Aug;11(1):1-11. doi: 10.1385/ENDO:11:1:1. Endocrine. 1999. PMID: 10668635 Review. - Inflammation, depression and cardiovascular disease in women: the role of the immune system across critical reproductive events.
Mattina GF, Van Lieshout RJ, Steiner M. Mattina GF, et al. Ther Adv Cardiovasc Dis. 2019 Jan-Dec;13:1753944719851950. doi: 10.1177/1753944719851950. Ther Adv Cardiovasc Dis. 2019. PMID: 31144599 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials